These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1461301)

  • 1. [Amyloidosis; pathogenesis and therapy].
    Witteman EM; Janssen HL; Hazenberg BP; Janssen S
    Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2318-22. PubMed ID: 1461301
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.
    Koudinova NV; Berezov TT; Koudinov AR
    Biochemistry (Mosc); 1999 Jul; 64(7):752-7. PubMed ID: 10424897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What causes Abeta amyloidosis in the brain?].
    Matsubara E; Yanagisawa K
    No To Shinkei; 2005 Oct; 57(10):829-38. PubMed ID: 16277228
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and therapy of dialysis amyloidosis].
    Homma N; Gejyo F; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():817-23. PubMed ID: 1578773
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
    Tennent GA; Lovat LB; Pepys MB
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4299-303. PubMed ID: 7753801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transition from physiological to pathophysiological indices as exemplified by amyloidosis in periodic disease, non-insulin-dependent diabetes mellitus, and Alzheimer's disease].
    Piruzian LA; Leksina LA
    Fiziol Cheloveka; 2009; 35(1):107-20. PubMed ID: 19323434
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein chemistry. In the footsteps of alchemists.
    Dobson CM
    Science; 2004 May; 304(5675):1259-62. PubMed ID: 15166354
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunolocalization of the amyloid precursor protein within the senile plaque.
    Perry G; Siedlak S; Mulvihill P; Kancherla M; Mijares M; Kawai M; Gambetti P; Sharma S; Maggiora L; Cornette J
    Prog Clin Biol Res; 1989; 317():1021-5. PubMed ID: 2513580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease.
    Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):37-46. PubMed ID: 10099838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of amyloidosis-beta and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in culture.
    Kolecki R; Lafauci G; Rubenstein R; Mazur-Kolecka B; Kaczmarski W; Frackowiak J
    Acta Neuropathol; 2008 Oct; 116(4):419-24. PubMed ID: 18483741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease.
    Gandy S; Caporaso G; Buxbaum J; Frangione B; Greengard P
    Neurobiol Aging; 1994; 15(2):253-6. PubMed ID: 7838304
    [No Abstract]   [Full Text] [Related]  

  • 13. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
    Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
    Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspases land on APP: one small step for apoptosis, one giant leap for amyloidosis?
    Tanzi RE
    Nat Neurosci; 1999 Jul; 2(7):585-6. PubMed ID: 10404170
    [No Abstract]   [Full Text] [Related]  

  • 16. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.
    Lu DC; Rabizadeh S; Chandra S; Shayya RF; Ellerby LM; Ye X; Salvesen GS; Koo EH; Bredesen DE
    Nat Med; 2000 Apr; 6(4):397-404. PubMed ID: 10742146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyloidosis: new facts, disputable and unresolved problems].
    Serov VV
    Arkh Patol; 1989; 51(10):3-10. PubMed ID: 2692539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model.
    Lichtenthaler SF; Haass C
    J Clin Invest; 2004 May; 113(10):1384-7. PubMed ID: 15146234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amylin and amyloidosis of the pancreatic islets and their significance in the etiology and pathogenesis of diabetes mellitus type 2].
    Kamaeva OI
    Ter Arkh; 1993; 65(10):14-7. PubMed ID: 8296225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.